Liposomal curcumin and its application in cancer
- PMID: 28860764
- PMCID: PMC5573051
- DOI: 10.2147/IJN.S132434
Liposomal curcumin and its application in cancer
Abstract
Curcumin (CUR) is a yellow polyphenolic compound derived from the plant turmeric. It is widely used to treat many types of diseases, including cancers such as those of lung, cervices, prostate, breast, bone and liver. However, its effectiveness has been limited due to poor aqueous solubility, low bioavailability and rapid metabolism and systemic elimination. To solve these problems, researchers have tried to explore novel drug delivery systems such as liposomes, solid dispersion, microemulsion, micelles, nanogels and dendrimers. Among these, liposomes have been the most extensively studied. Liposomal CUR formulation has greater growth inhibitory and pro-apoptotic effects on cancer cells. This review mainly focuses on the preparation of liposomes containing CUR and its use in cancer therapy.
Keywords: bioavailability; cancer; curcumin; drug delivery; liposomes.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Figures
References
-
- Giacosa A, Morazzoni P, Bombardelli E, Riva A, Bianchi Porro G, Rondanelli M. Can nausea and vomiting be treated with ginger extract? Eur Rev Med Pharmacol Sci. 2015;19(7):1291–1296. - PubMed
-
- Lang JY. The concept and prospect of combined for tumor. Cancer Control Treat. 2008;21(2):116–118.
-
- Di Maio M, Basch E, Bryce J, Perrone F. Patient-reported outcomes in the evaluation of toxicity of anticancer treatments. Nat Rev Clin Oncol. 2016;13(5):951–955. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
